Clinical Trial Update: Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating epoetin beta for treating anemia and fatigue in adults with malignant solid tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor

Drugs mentioned

• NeoRecormon (epoetin beta)

Snippet

Sponsor: Centre Hospital Regional Universitaire de Limoges | Conditions: Anemia, Fatigue | Phase 2 | Status: COMPLETED